Home / NYC Vascular Disease Screening
This is an ultrasound test to determine if there is blockage of blood flow in a particular artery. It is frequently used in the carotid artery to determine if there is risk of stroke or looking for a cause of fainting.
A vascular ultrasound is safe, noninvasive, effective, and painless. (It’s the same technology used to image babies in the womb of pregnant women.) This cardiac test is primarily used to determine if an individual has significant plaque in the carotid artery which would increase the risk of stroke. Vascular disease screening is a painless, noninvasive test. The ultrasound takes about 30 minutes to complete. Please plan to arrive about 15 minutes before your scheduled appointment to complete the registration process.
Brilliant and thorough cardiologist. Very pleasant to deal with. HIGHLY RECOMMENDED. I would definitely say that Dr Reisman is the best Manhattan Cardiologist (I shopped around). ~ ZocDoc
A Vascular Ultrasound is performed by our specially trained technologists after consultation with the best in class cardiology doctor Dr. Reisman and may be used to evaluate one or more of the following conditions:
Doctor’s Note: Cigarette smoking may change the results of a vascular ultrasound because nicotine can cause the arteries to shrink (constrict). Please try not to smoke for a few hours before your test.
If you have any questions for the best in class NYC cardiologist or would like to schedule a consultation or appointment please feel free to contact Dr. Steven Reisman of the New York Cardiac Diagnostic Center and indicate which Manhattan office (Upper East Side, Midtown Manhattan, or Wall Street / Financial District) you would like to see the cardiologist for a cardiac consultation.
Dr. Steven Reisman is an internationally recognized cardiologist and heart specialist. He is a member of the American College of Cardiology, American Heart Association, and a founding member of the American Society of Nuclear Cardiology.
Dr. Reisman has presented original research findings for the early detection of "high risk" heart disease and severe coronary artery disease at the annual meetings of both the American College of Cardiology and the American Heart Association. Dr. Reisman was part of a group of doctors with the Food and Drug Administration who evaluated the dipyridamole thallium testing technique before the FDA approved it.
Dr. Steven Reisman's academic appointments include Assistant Professor of Medicine at the University of California and Assistant Professor at SUNY. Hospital appointments include the Director of Nuclear Cardiology at the Long Island College Hospital.